FOXA1 and prostate carcinoma: Finally, to confirm FOXA1 3′-UTR mutations in whole-genome sequencing data, we studied a published cohort of 52 metastatic tissue samples from 10 prostate cancer patients17, and identified FOXA1 3′-UTR mutations in two patients.